Menu
Back to Journals » Infection and Drug Resistance
Infection and Drug Resistance
ISSN: 1178-6973
- View all (3546)
- Volume 17, 2024 (152)
- Volume 16, 2023 (705)
- Volume 15, 2022 (735)
- Volume 14, 2021 (553)
- Volume 13, 2020 (470)
- Volume 12, 2019 (399)
- Volume 11, 2018 (262)
- Volume 10, 2017 (60)
- Volume 9, 2016 (34)
- Volume 8, 2015 (39)
- Volume 7, 2014 (38)
- Volume 6, 2013 (25)
- Volume 5, 2012 (20)
- Volume 4, 2011 (23)
- Volume 3, 2010 (16)
- Volume 2, 2009 (5)
- Volume 1, 2008 (10)
Journal Articles:
- Antimicrobial Stewardship and Infection Control: A Global Perspective (2)
- Current aspects of fungal infections (1)
- Advances in Osteomyelitis: Pathogenesis, Diagnosis, and Treatment (1)
- Respiratory Syncytial Virus (RSV): progress, challenges and outcomes (6)
The Emergence of Candida auris is Not Associated with Changes in Antifungal Prescription at Hospitals
Wong SC, Chau PH, Chen H, So SY, Chiu KH, Chen JH, Li X, Chui CS, Yuen KY, Cheng VC
Infection and Drug Resistance 2024, 17:1419-1429
Published Date: 11 April 2024
Mechanisms of Antibiotic Resistance and Developments in Therapeutic Strategies to Combat Klebsiella pneumoniae Infection
Li Y, Kumar S, Zhang L
Infection and Drug Resistance 2024, 17:1107-1119
Published Date: 19 March 2024
COVID-19-Associated Rhinocerebral Mucormycosis, an Incidental Finding or a Matter of Concern – Mixed-Method Systematic Review
Andreescu M, Moldovan C, Lespezeanu DA, Mocanu AI, Schipor MA, Mocanu H
Infection and Drug Resistance 2024, 17:387-402
Published Date: 31 January 2024
Similarities and Differences Between Diabetes-Related and Trauma-Related Calcaneal Osteomyelitis: Comparisons Based on 681 Reported Cases
Liu GQ, Chen P, Huang MZ, Song MR, Song CS, Zhu RJ, Xiong J, Jiang N, Yu B
Infection and Drug Resistance 2023, 16:7547-7557
Published Date: 8 December 2023
New Developments and Challenges in Antibody-Based Therapies for the Respiratory Syncytial Virus
Diethelm-Varela B, Soto JA, Riedel CA, Bueno SM, Kalergis AM
Infection and Drug Resistance 2023, 16:2061-2074
Published Date: 8 April 2023
The Impact of the COVID-19 Pandemic on Respiratory Syncytial Virus Infection: A Narrative Review
Chuang YC, Lin KP, Wang LA, Yeh TK, Liu PY
Infection and Drug Resistance 2023, 16:661-675
Published Date: 30 January 2023
Responding to Higher-Than-Expected Infant Mortality Rates from Respiratory Syncytial Virus (RSV): Improving Treatment and Reporting Strategies
Dvorkin J, De Luca J, Alvarez-Paggi D, Caballero MT
Infection and Drug Resistance 2023, 16:595-605
Published Date: 27 January 2023
Epidemiological Trend of RSV Infection Before and During COVID-19 Pandemic: A Three-Year Consecutive Study in China
Qiu W, Zheng C, Huang S, Zhang Y, Chen Z
Infection and Drug Resistance 2022, 15:6829-6837
Published Date: 28 November 2022
Age-Dependent Clinical Characteristics of Acute Lower Respiratory Infections in Young Hospitalized Children with Respiratory Syncytial Virus Infection
Li L, Wang H, Liu A, Chen J, Yang Y, Wang W
Infection and Drug Resistance 2022, 15:5971-5979
Published Date: 18 October 2022
Performance Evaluation of TaqMan SARS-CoV-2, Flu A/B, RSV RT-PCR Multiplex Assay for the Detection of Respiratory Viruses
Neopane P, Nypaver J, Shrestha R, Beqaj S
Infection and Drug Resistance 2022, 15:5411-5423
Published Date: 12 September 2022